A business leader in the Biotechnology/Pharmaceutical Industry, Paul has a proven track record of business growth, transformation and performance, building high performing cultures and experience leading people and business in biotechnology and rare disease in both Canada, the United States and Europe. His experience includes leading business with such companies as GlaxoSmthKline, Astra Zeneca and General Management roles with Biogen, Jazz Pharmaceuticals and of recent Gilead Sciences Canada Inc. Paul’s experience and success transcend the financials, as he puts people first. The foundation of his leadership approach is based on creating a winning culture, prioritizing people and teams and championing diversity, inclusion and equity. Paul is an advocate for equitable healthcare in Canada, champion policy and advocating for patients. His success in creating a winning culture in companies he has led has been recognized by Great Place to Work in Canada and Greater Toronto Top Employer.
Paul’s commitment to business and people leadership goes beyond his current role, where he is active as a member of the board with Health Partners Canada, Biotech Canada and Kapoose Creek Bio. Paul also serves as faculty for the Marketing Pharmaceuticals in Canada Program, The National Pharmaceutical Congress, and McMaster University Biomedical Discovery and Commercialization Graduate Program. His industry leadership has also been recognized through speaking engagements at The Market Access Summit, Science to business network and Women in Pharma, just to name a few.
His leadership in Biotech has been recognized by being included in the Canadian Pharmaceutical Hall of Fame and is a Biotech Canada Gold Leaf Award recipient.
Paul has BSc in Biology, Genetics, from the University of Toronto and a graduate of the Institute of Corporate Directors program at the Rotman School of Management, University of Toronto.